GE's Culp Is On Track To Slash Debt By Up To $38 Billion, Possibly In Q3 '19 [Seeking Alpha]
Danaher Corporation (DHR)
Last danaher corporation earnings: 1/30 06:00 am
Check Earnings Report
US:NYSE Investor Relations:
investors.danaher.com
Company Research
Source: Seeking Alpha
GE's Culp Is On Track To Slash Debt By Up To $38 Billion, Possibly In Q3 '19 - Danaher Corporation (NYSE:DHR) | Seeking Alpha Quick Picks & Lists | Conglomerates 's Culp Is On Track To lash Debt By Up To $38 Billion, Possibly In Q3 '19 ep. 9, 2019 6:00 AM ET About: Danaher Corporation (DHR) by: Robert Honeywill Long only Marketplace Analysts Cnr | H2 uperGrid ummary Announcements by both and Danaher, of 's sale of its BioPharma business to Danaher, stated the transaction was expected to close in 4th quarter 2019. Danaher already has the cash organized, and it could be in the interests of both parties to push for the $21 billion transaction to now close in 3rd Quarter 2019. I discuss the implications for General Electric and Danaher and what makes this a compelling move for both companies. I explain how sale of 's remaining interest in , at current share price, has the potential to reduce 's net debt by a surprising $16 billion. Markopolos has created an unexpected opportunity to b
Show less
Read more
Impact Snapshot
Event Time:
DHR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DHR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DHR alerts
High impacting Danaher Corporation news events
Weekly update
A roundup of the hottest topics
DHR
News
- Biotherapeutics Cell Line Development Strategic Business Research Report 2024-2030: Rising Investments in Biosimilar Development Creating New Opportunities [Yahoo! Finance]Yahoo! Finance
- Coding & Marking Equipment Industry Forecast Report, 2025-2030: Emerging Trends, Opportunities, Regional Market Insights, Competitive Intelligence [Yahoo! Finance]Yahoo! Finance
- The ‘North Star' Is 46 Times Bigger Than The Sun And ‘Spotty', Scientists Say [Forbes]Forbes
- $55.7 Billion Biopharmaceutical Fermentation Systems Market Opportunities and Strategies to 2033: Development of New Bioreactors to Enhance Single-Use Upstream Operations, New Technology Developments [Yahoo! Finance]Yahoo! Finance
- [Latest] Global Pharmaceutical Membrane Filtration Market Size/Share Worth USD 27,620 Million by 2033 at a 13.4% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value) [Yahoo! Finance]Latest
DHR
Earnings
- 10/22/24 - Beat
DHR
Sec Filings
- 11/22/24 - Form 4
- 11/22/24 - Form 4
- 11/22/24 - Form 4
- DHR's page on the SEC website